Once again, GlaxoSmithKline has been accused of gaming the patent system to fend off generic competition for its popular antidepressant Paxil.
Microsoft Corp. is launching a new licensing program to mine its growing patent portfolio more aggressively and to position the company better as it faces an onslaught of patent infringement lawsuits, according to a published report.
In a case with broad implications for interpretations of the Digital Millennium Copyright Act, the U.S. Supreme Court has refused to hear an appeal from the Chamberlain Group in its patent dispute with Skylink Technologies Inc. over aftermarket products.
A federal judge has approved SmithKline Beecham's $65 million settlement of a class-action antitrust suit brought by consumers who accused the U.K. drug maker of filing "sham" patent lawsuits to delay generic competition for antidepressant Paxil.
Dykema Gossett PLLC has hired former Brinks Hofer Gilson & Lione partner Allan J. Sternstein to take the helm of the firm’s intellectual property litigation team.
In an ominous development for European futures traders, the European Patent Office has awarded a broad patent to a software maker that has vowed to take on the entire industry in an effort to obtain licensing agreements for its trading platform.
A Chicago software vendor that has rattled the futures industry with patent litigation has sued U.K.-based Man Group, one of the largest futures brokerages in the world.
In a blow to U.K. drug maker GlaxoSmithKline, the U.S. Court of Appeals for the Federal Circuit has ruled in favor of Canadian generics maker Apotex in a patent infringement lawsuit over the best-selling antidepressant Paxil.
Quest Software Inc. has agreed to pay Computer Associates $16 million plus royalties under a non-exclusive licensing agreement as part of a settlement of a copyright and trade-secrets lawsuit.
Microsoft has filed an appeal in the patent infringement case brought by Eolas Technologies, seeking to overturn the claim on foreign sales of the Internet Explorer browser.
The University of California topped the U.S. Patent and Trademark Office’s list of top university patent recipients in 2004, a position the state’s public university system has held for more than a decade.
In a significant legal victory for Microsoft, the U.S. Court of Appeals for the Federal Circuit has reversed and remanded the validity and inequitable conduct issues in a $521 million patent lawsuit over the software maker’s browser technology.
A software vendor that has rattled the futures industry with threats of patent litigation has sued a broker with clients trading on all four of the leading futures exchanges.
In a move that could wipe out much of Canada’s billion-dollar internet pharmacy industry, the government is considering banning the export of patented prescription drugs to the U.S.
A federal judge has denied Trading Technologies’ motion for an injunction against Cantor Fitzgerald's eSpeed derivatives division, but acknowledged in his decision that there is “a clear showing of patent validity and infringement.”
A federal court in Illinois has awarded Swanson Tool Company more than $600,000 in a trademark counterfeiting lawsuit which remains pending against several other defendants.
In a deal that closely resembles similar settlements for arthritis drug Relafen and prescription antibiotic Augmentin, GlaxoSmithKline has reportedly agreed to pay $65 million to settle a class action antitrust suit brought by consumers who accused the U.K. drug maker of filing "sham" patent lawsuits to delay generic competition for antidepressant Paxil.
Multimedia software maker Ingenient Technologies Inc. has sued rival PacketVideo and two former employees for copyright infringement and misappropriation of trade secrets.
In a blow to U.K. drug maker GlaxoSmithKline PLC, the European Court of Justice has ruled that generic drug makers should be allowed to market versions of its top-selling anti-depressant Seroxat, marketed in the U.S. as Paxil.
The Court of Appeals for the Federal Circuit has denied the University of Illinois’ request for a rehearing of its appeal for sovereign immunity in a patent dispute over plasma displays with Japanese electronics maker Fujitsu.